Tri Locum Partners as of June 30, 2026
Portfolio Holdings for Tri Locum Partners
Tri Locum Partners holds 19 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | 13.3 | $108M | 425k | 253.97 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 12.3 | $100M | 202k | 496.73 | |
| Eli Lilly & Co. (LLY) | 11.3 | $92M | 77k | 1199.43 | |
| Ascendis Pharma A/s Ord Shs (ASND) | 8.5 | $69M | 259k | 266.72 | |
| Dex (DXCM) | 6.8 | $55M | 821k | 67.35 | |
| Axsome Therapeutics (AXSM) | 6.6 | $54M | 219k | 244.77 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 6.6 | $53M | 222k | 240.97 | |
| Enliven Therapeutics (ELVN) | 5.4 | $44M | 867k | 50.75 | |
| Argenx Se Sponsored Adr (ARGX) | 4.7 | $39M | 42k | 927.77 | |
| Madrigal Pharmaceuticals (MDGL) | 4.5 | $37M | 68k | 536.95 | |
| Revolution Medicines (RVMD) | 3.5 | $28M | 152k | 187.28 | |
| United Therapeutics Corporation (UTHR) | 3.1 | $26M | 47k | 541.83 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 3.1 | $25M | 747k | 33.88 | |
| Tarsus Pharmaceuticals (TARS) | 2.5 | $21M | 328k | 62.94 | |
| Intuitive Surgical Com New (ISRG) | 2.3 | $19M | 48k | 397.68 | |
| Cytokinetics Com New (CYTK) | 2.0 | $17M | 194k | 85.19 | |
| Dianthus Therapeutics (DNTH) | 1.4 | $12M | 121k | 97.48 | |
| Beta Bionics (BBNX) | 1.0 | $7.7M | 493k | 15.67 | |
| Definium Therapeutics Com Shs (DFTX) | 0.9 | $7.7M | 163k | 47.04 |
